GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baxter International Inc (WBO:BAX) » Definitions » 3-Year Share Buyback Ratio

Baxter International (WBO:BAX) 3-Year Share Buyback Ratio : -0.60% (As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Baxter International 3-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Baxter International's current 3-Year Share Buyback Ratio was -0.60%.

The historical rank and industry rank for Baxter International's 3-Year Share Buyback Ratio or its related term are showing as below:

WBO:BAX' s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -5.1   Med: -0.1   Max: 3.1
Current: -0.6

During the past 13 years, Baxter International's highest 3-Year Share Buyback Ratio was 3.10%. The lowest was -5.10%. And the median was -0.10%.

WBO:BAX's 3-Year Share Buyback Ratio is ranked better than
65.89% of 645 companies
in the Medical Devices & Instruments industry
Industry Median: -2.9 vs WBO:BAX: -0.60

Competitive Comparison of Baxter International's 3-Year Share Buyback Ratio

For the Medical Instruments & Supplies subindustry, Baxter International's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Baxter International's 3-Year Share Buyback Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Baxter International's 3-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Baxter International's 3-Year Share Buyback Ratio falls into.


;
;

Baxter International 3-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Baxter International (WBO:BAX) 3-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.


Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.


Baxter International 3-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Baxter International's 3-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Baxter International Business Description

Address
One Baxter Parkway, Deerfield, IL, USA, 60015
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.